InvestorRelations

Please contact us for any investor information using the form below.

CurrentNews

EmpowerPharm Inc. Announces First Patient Dosed in a Phase II Study Evaluating Empower CBD™ for the Treatment of Social Anxiety Disorder

EmpowerPharm Inc a clinical-stage life sciences company focused on research and clinical development announced today that the first patient has been dosed in their Company-sponsored Phase II clinical study.

Read More →

EmpowerPharm Inc. Announces First Patient Enrolled in a Phase II Study Evaluating Empower CBD™ for the Treatment of Social Anxiety Disorder

EmpowerPharm Inc a clinical-stage life sciences company focused on research and clinical development announced today that the first patient has been enrolled in their Company-sponsored Phase II clinical study.

Read More →

EmpowerPharm Inc. welcomes Terri-Jean (TJ) Geddis

TJ is a commercial leader with over 25 years of experience in both the pharmaceutical and biotech industries. She started her career at larger companies such as Eli Lilly and with her entrepreneurial mindset, gravitated to smaller, Canadian start-up organizations such as Alexion and Mitsubishi Tanabe Pharma.

Read More →

Subscribe to get the latest news.